Beyond PARP Inhibitors: Agents in Pipelines Target DNA Repair Mechanisms

被引：7
|
作者：
Maxmen, Amy
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2010年 / 102卷 / 15期
关键词：
D O I：
10.1093/jnci/djq294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1110 / 1111
页数：2
相关论文
共 50 条
  • [21] Exploiting DNA repair vulnerabilities with PARP inhibitors to stimulate anti-tumor immunity
    Chabanon, Roman M.
    Postel-Vinay, Sophie
    M S-MEDECINE SCIENCES, 2019, 35 (10): : 728 - 731
  • [22] Posttranscriptional Regulation of PARG mRNA by HuR Facilitates DNA Repair and Resistance to PARP Inhibitors
    Chand, Saswati N.
    Zarei, Mahsa
    Schiewer, Matthew J.
    Kamath, Akshay R.
    Romeo, Carmella
    Lal, Shruti
    Cozzitorto, Joseph A.
    Nevler, Avinoam
    Scolaro, Laura
    Londin, Eric
    Jiang, Wei
    Meisner-Kober, Nicole
    Pishvaian, Michael J.
    Knudsen, Karen E.
    Yeo, Charles J.
    Pascal, John M.
    Winter, Jordan M.
    Brody, Jonathan R.
    CANCER RESEARCH, 2017, 77 (18) : 5011 - 5025
  • [23] Differential PARP inhibitors' effects on cell cycle and consequently homologous DNA damage repair
    Jelinic, Petar
    Levine, Douglas A.
    CANCER RESEARCH, 2014, 74 (19)
  • [24] Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Cancer
    Muvarak, Nidal E.
    Chowdhury, Khadiza
    Xia, Limin
    Robert, Carine
    Choi, Eun Yong
    Cai, Yi
    Bellani, Marina
    Zou, Ying
    Singh, Zeba N.
    Duong, Vu H.
    Rutherford, Tyler
    Nagaria, Pratik
    Bentzen, Soren M.
    Seidman, Michael M.
    Baer, Maria R.
    Lapidus, Rena G.
    Baylin, Stephen B.
    Rassoo, Feyruz V.
    CANCER CELL, 2016, 30 (04) : 637 - 650
  • [25] Inhibition of PARG sensitizes ovarian cancer cells to PARP inhibitors and DNA damaging agents
    Matanes, E.
    Kogan, L.
    Lopez-Ozuna, V.
    Mitric, C.
    Raban, O.
    Eisenberg, N.
    Baloch, T.
    Salvador, S.
    Lau, S.
    Gotlieb, W. H.
    Yasmeen, A.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 137 - 137
  • [26] INHIBITION OF PARG, SENSITIZES OVARIAN CANCER CELLS TO PARP INHIBITORS AND DNA DAMAGING AGENTS
    Matanes, Emad
    Baloch, Tahira
    Octeau, David
    Kessous, Roy
    Kogan, Liron
    Laskov, Ido
    Gotlieb, Walter
    Yasmeen, Amber
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 228 - 228
  • [27] Beyond PARP-POLθ as an anticancer target
    Higgins, Geoff S.
    Boulton, Simon J.
    SCIENCE, 2018, 359 (6381) : 1217 - +
  • [28] PARP Inhibitors in Breast Cancer: BRCA and Beyond
    Rios, Jorge
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2011, 25 (11): : 1014 - 1025
  • [29] PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation
    Min, Ahrum
    Im, Seock-Ah
    CANCERS, 2020, 12 (02)
  • [30] PARP inhibitors in cancer: moving beyond BRCA
    Telli, Melinda L.
    LANCET ONCOLOGY, 2011, 12 (09): : 827 - 828
12345